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Objective: Clear depiction of the common bile duct is important when evaluating neonatal cholestasis in order to 
differentiate biliary atresia from other diseases. During MR cholangiopancreatography, the T2-shortening effect of 
gadolinium can increase the contrast-to-noise ratio (CNR) of the bile duct and enhance its depiction. The purpose of this 
study was to confirm, by performing a phantom study, the T2-shortening effect of gadolinium, to evaluate the effect 
of different gadolinium chelates with different gadolinium concentrations and different magnetic field strengths for 
investigating the optimal combination of these conditions, and for identifying the maximum CNR for the evaluation of the 
biliary system.
Materials and Methods: MR imaging using a T2-weighted single-shot fast spin echo sequence and T2 relaxometry was 
performed with a sponge phantom in a syringe tube. Two kinds of contrast agents (Gd-DTPA and Gd-EOB-DTPA) with 
different gadolinium concentrations were evaluated with 1.5T and 3T scanners. The signal intensities, the CNRs and the T2 
relaxation time were analyzed.
Results: The signal intensities significantly decreased as the gadolinium concentrations increased (p < 0.001) with both 
contrast agents. These signal intensities were higher on a 3T (p < 0.001) scanner. The CNRs were higher on a 1.5T (p < 
0.001) scanner and they showed no significant change with different gadolinium concentrations. The T2 relaxation time 
also showed a negative correlation with the gadolinium concentrations (p < 0.001) and the CNRs showed decrease more 
with Gd-EOB-DTPA (versus Gd-DTPA; p < 0.001) on a 3T scanner (versus 1.5T; p < 0.001).
Conclusion: A T2-shortening effect of gadolinium exhibits a negative correlation with the gadolinium concentration for 
both the signal intensities and the T2 relaxation time. A higher CNR can be obtained with Gd-DTPA on a 1.5T MRI scanner. 
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INTRODUCTION
Magnetic resonance (MR) imaging has developed 
as an efficient and noninvasive imaging tool for 
making the diagnosis of pancreaticobiliary disease. MR 
cholangiopancreatography (MRCP) and the gadolinium-
enhanced T1-weighted images can be used for this purpose.
MR cholangiopancreatography relies on the use of a 
heavily T2-weighted sequence. Stationary tissue with a 
long T2 relaxation time (including water and bile) has high 
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signal intensity. In contrast, tissues with short T2 relaxation 
times (such as the liver and pancreas) and flowing blood 
(signal loss from motion) have low signal intensity. This 
allows for optimal contrast between the hyperintense bile 
and the hypointense background (1). In clinical practice, 
MRCP can be used to depict and evaluate the major biliary 
structures of neonates and small infants to exclude biliary 
atresia as the cause of neonatal cholestasis by allowing 
visualization of the common bile duct (2, 3).  
The gadolinium-enhanced T1 sequence is also useful for 
evaluating pancreaticobiliary disease. The paramagnetic 
gadolinium-containing MRI contrast agents are sometimes 
termed “positive contrast agents” based on their effective 
T1-shortening characteristics, which provide an increased 
signal intensity in the T1-weighted sequences (4). However, 
gadolinium chelate is known to have not only a T1-
shortening effect, but also T2- and T2*-shortening effects. 
Therefore, it can darken the area of contrast distribution 
depending on its concentration on the T2-weighted images 
(5-8). Additionally, the effects of T1- and T2-shortening 
compete, that is, T1-shortening usually leads to increased 
signal intensity in an image while T2-shortening results in 
decreased signal intensity (6). 
While some studies have been performed regarding the 
efficacy of additional gadolinium chelate administration for 
depicting biliary structures as compared with conventional 
T2-weighted MRCP for the purpose of improving the 
diagnosis, the results have been controversial (1, 5). 
Moreover, the efficacy of gadolinium agents is determined 
not only by their pharmacokinetic properties, but also by 
their magnetic properties (T1- and T2-relaxivities) (4). 
Various factors (including contrast agents, the magnetic 
field strength and temperature) can influence these 
relaxivities. 
There are many kinds of gadolinium chelate; the 
majority of the agents are predominantly excreted through 
A B
C
Fig. 1. Size comparison between normal neonate liver, common 
bile duct and sponge phantom. 
T2-weighted coronal (A) and axial (B) images of normal neonate liver 
and axial image of sponge phantom (C) (all magnified by same factor) 
seem to be similar in size. Also, diameter of common bile duct (2 mm, 
arrow in A) in normal neonate is similar with inner diameter of 1 cc 
syringe tube (3 mm, arrow in C) in sponge phantom.
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the kidneys and not through the biliary system. These 
contrasts agents affect the signal intensity not in the bile 
ducts, but in the surrounding soft tissue. However, some 
contrast agents (hepatobiliary contrast agents) are cleared 
from the body by both urinary and biliary routes (4, 9). 
Visualization of the bile ducts can be enhanced with these 
agents in T1-weighted MRCP (10). Therefore, these different 
characteristics of contrast excretion can be used in both T1- 
and T2-weighted MRCP. 
Further, the clinical condition of the patient can be an 
important factor. In evaluating neonatal cholestasis, the 
use of gadolinium is limited in patients with biliary atresia 
due to delayed biliary excretion. Yet no previous study has 
evaluated the proper delay time or the optimal gadolinium 
concentration to increase the contrast-to-noise ratio (CNR) 
for the evaluation of biliary trees in cases with delayed 
biliary excretion. 
The purpose of this study was to confirm the T2-
shortening effect of gadolinium, to evaluate the effect 
of different gadolinium chelates and different magnetic 
field strengths to identify the optimal combination of 
these conditions, and to determine the maximum CNR for 
evaluating the biliary system through a phantom study. 
MATERIALS AND METHODS
Phantom Study
We prepared two sponge phantoms in a rectangular 
plastic container to simulate background soft tissue. A 1 cc  
syringe tube was placed in each sponge phantom to 
simulate a bile duct (Fig. 1). Gadopentetate dimeglumine 
(Gd-DTPA, Magnevist; Bayer Schering Pharma, Germany) or 
gadoxetic acid disodium (Gd-EOB-DTPA, Primovist; Bayer 
Schering Pharma, Germany) was added to normal saline to 
create different gadolinium concentrations. 
One container was used for Gd-DTPA. At first, a plain 
sponge phantom with normal saline was evaluated to 
simulate the background soft tissue before contrast 
administration. Next, Gd-DTPA was dissolved at 
concentrations of 0.1, 0.3, 0.5, 0.7, and 1.0 mmol/L to 
simulate the background after contrast administration 
(5, 11). The tubes were filled with normal saline in this 
container.
The other container held a sponge phantom with Gd-EOB-
DTPA. Gd-EOB-DTPA was also dissolved at concentrations 
of 0, 0.1, 0.3, 0.5, 0.7, and 1.0 mmol/L in this sponge 
phantom. The tubes were filled with Gd-EOB-DTPA with 
different concentrations of 0, 0.5, 1, 1.5, 2, 2.5, and 3 
mmol/L in this container (8). 
These two sponge phantoms were scanned simultaneously 
with the same level of gadolinium concentration.
MR Imaging
MR imaging was performed with 1.5-T and 3T scanners 
(Intera Achieva; Philips Medical Systems, Amsterdam, 
The Netherlands) using a coil produced by the scanner 
manufacturer (SENSE head; Philips Medical Systems). Two 
sponge phantoms were imaged with a T2-weighted single-
shot fast spin echo sequence (TR/TE: 620/80, echo-
train length: 56, half-Fourier acquisition, matrix: 212 × 
210, field of view: 20 × 20 cm, section thickness: 3 mm, 
received bandwidth: 54.7 kHz on the 1.5T scanner and TR/
TE: 960/80, echo-train length: 58, half-Fourier acquisition, 
matrix: 256 × 256, field of view: 20 × 20 cm, section 
thickness: 3 mm, received bandwidth: 41.4 kHz on the 3T 
scanner).
To evaluate the T2 relaxation time of each sponge 
phantom, T2 relaxometry was performed with the spin-echo 
sequences (TR/TE: 2000/20, 40, 60, 80, 100, 120, 140, 
160, 180 and 200) and the same coil.  
Image Analysis
Image analysis was conducted using operator-defined 
region-of-interest measurements of the mean signal 
intensity of the inner area of the tube and the sponge. 
The mean signal intensity was obtained from the signal 
intensities at three sites for each area. 
To simulate the CNR of bile ducts in the liver, the CNR of 
the syringe tube was calculated by dividing the difference 
between the mean signal intensities of the sponge and the 
syringe tube by the standard deviation of the mean signal 
intensity of the sponge. 
The T2 relaxation time of each sponge phantom was 
recorded from the T2 relaxometry images. Least square 
fitting was used to calculate the relaxation time. 
The signal intensities, CNRs and T2 relaxation time 
of the two phantoms (with Gd-DTPA and Gd-EOB-DTPA) 
with different magnetic field strengths (1.5T and 3T) 
were compared and correlated with the gadolinium 
concentrations. The maximum value of the CNR for each set 
of conditions was also evaluated.
Statistical Analysis
The changes in the mean signal intensities, the CNRs 
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and the T2 relaxation times were compared for each set of 
conditions (with different gadolinium chelates and different 
magnetic field strengths) using repeated ANOVA (analysis 
of variance). The relationships between these parameters 
(signal intensities, CNRs and T2 relaxation times) and the 
gadolinium concentrations were evaluated with a linear 
regression test and the regression slopes were obtained. 
Statistical analysis was performed using statistical 
software (SPSS, version 17; SPSS, Chicago, IL). Statistically 
significant differences were defined when the p values were 
less than 0.05.
Table 1. Relationship between Parameters (Signal Intensities, CNRs and T2 Relaxation Times) and Gadolinium 
Concentrations
1.5T 3T
R² Regression Slope P Value* R² Regression Slope P Value*
SI DTPA 0.906 -96.015 < 0.001 0.087 -292.044 0.030
EOB 0.919 -116.309 < 0.001 0.091 -327.107 0.026
CNR DTPA 0.001 -1.457 0.783 0.004 1.070 0.637
EOB 0.001 -0.857 0.871 0.006 1.219 0.586
T2 DTPA 0.652 -2.602 < 0.001 0.485 -1.488 < 0.001
EOB 0.779 -2.439 < 0.001 0.725 -1.494 < 0.001
Note.— *from linear regression analysis. CNR = contrast-to-noise ratio, DTPA = Gd-DTPA, EOB = Gd-EOB-DTPA, SI = signal 
intensity, T2 = T2 relaxation time
Fig. 2. Line chart depicting relationship between signal 
intensities and gadolinium concentrations with different 
gadolinium chelates and different magnetic field strengths. 
Signal intensities of sponge phantom decreased as concentration of 
gadolinium chelate increased under all conditions; these were higher 
on 3T. ANOVA = analysis of variance, DTPA = Gd-DTPA, EOB = Gd-EOB-
DTPA
Gd concentration (mmol/L)
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Gd concentration: p < 0.001
Contrast: p > 0.05
Tesla: p < 0.001
(from repeated ANOVA)
RESULTS
The relationships between the parameters (signal 
intensities, CNRs and T2 relaxation times) and the different 
gadolinium concentrations are summarized in Table 1. The 
results of comparing the parameters between the different 
gadolinium chelates are summarized in Table 2. The results 
about the magnetic field strength showed that the magnetic 
field strength significantly influenced all the parameters 
with both gadolinium chelates (p < 0.001).
The signal intensities showed a significantly negative 
correlation with the gadolinium concentration for both 
contrast agents in both magnetic field strengths (Fig. 
Fig. 3. Line chart depicting relationship between contrast-
to-noise ratios and gadolinium concentrations with different 
gadolinium chelates on different magnetic field strengths. 
Contrast-to-noise radios of tube in sponge phantom were not 
correlated with gadolinium concentration. However, contrast-to-
noise ratios were higher on 1.5T with both contrast agents. ANOVA = 
analysis of variance, DTPA = Gd-DTPA, EOB = Gd-EOB-DTPA
Gd concentration (mmol/L)
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Gd concentration: p < 0.5
Contrast: p > 0.05
Tesla: p < 0.001
(from repeated ANOVA)
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2) (Table 1). The signal intensities were higher with 3T 
for both contrast agents (p < 0.001). However, there 
was no statistically significant difference between the 
two gadolinium chelates in either of the magnetic field 
strengths (p = 0.149 on 1.5T and p = 0.144 on 3T) (Table 2). 
The CNRs showed no correlations with the gadolinium 
concentrations under any set of conditions (Fig. 3) (Table 1). 
The CNRs did not change depending on the contrast agent (p 
= 0.824 on 1.5T and p = 0.660 on 3T) (Table 2). However, 
the CNRs were higher on 1.5T with both contrast agents (p 
< 0.001). The maximum CNR could not be obtained for this 
result.
The CNRs of Gd-EOB-DTPA with the different tube 
gadolinium concentrations were also analyzed with both 1.5T 
(Fig. 4A) and 3T (Fig. 4B). The CNRs showed a significant 
correlation with the gadolinium concentrations on 3T (p = 
0.007), but not on 1.5T (p = 0.107). There were significant 
differences between the different tube gadolinium 
concentrations on both 1.5T and 3T (p < 0.001). However, 
the maximum CNR could also not be obtained for this result.
The T2 relaxation time also decreased as the gadolinium 
concentration increased with both contrast agents for both 
magnetic field strengths (p < 0.001) (Fig. 5) (Table 1). The 
T2 relaxation times were longer with Gd-DTPA on both 1.5T 
(p < 0.001) and 3T (p = 0.006) (Table 2), and they were 
also longer on 1.5T with both contrast agents (p < 0.001). 
Table 2. Comparison of Parameters (Signal Intensities, 
CNRs and T2 Relaxation Times) between Different 
Gadolinium Chelates (DTPA versus EOB)
P Value* on 1.5T P Value* on 3T
SI 0.149 0.144
CNR 0.824 0.660
T2 < 0.001 0.006
Note.— *from repeated analysis of variance. CNR = contrast-
to-noise ratio, DTPA = Gd-DTPA, EOB = Gd-EOB-DTPA, SI = 
signal intensity, T2 = T2 relaxation time
Fig. 5. Line chart depicting relationship between T2 relaxation 
time and gadolinium concentration with different gadolinium 
chelates on different magnetic field strengths. 
T2 relaxation time decreased as gadolinium concentration increased in 
all conditions. T2 relaxation times were longer with Gd-DTPA on 1.5T.
 ANOVA = analysis of variance, DTPA = Gd-DTPA, EOB = Gd-EOB-DTPA
Gd concentration (mmol/L)
T2
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Gd concentration: p < 0.001
Contrast: p > 0.05
Tesla: p < 0.001
(from repeated ANOVA)
A B
Fig. 4. Line chart depicting relationship between contrast-to-noise ratios and gadolinium concentrations with Gd-EOB-DTPA on 1.5T (A) and 
3T (B). Different tube gadolinium concentrations (on both magnetic field strengths) and sponge gadolinium concentration changes (on 3T) had 
significantly influence on the contrast-to-noise ratios. ANOVA = analysis of variance
Gd concentration (mmol/L) Gd concentration (mmol/L)
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Gd concentration: p = 0.107
Tube Gd concentration: p < 0.001
Interaction: p = 0.002
(from repeated ANOVA)
Gd concentration: p = 0.007
Tube Gd concentration: p < 0.001
Interaction: p = 0.003
(from repeated ANOVA)
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DISCUSSION
As mentioned in the introduction, various factors can 
influence the magnetic properties of gadolinium agents and 
the efficacy of these contrast agents. Among these factors, 
we evaluated the effects of contrast agents, the magnetic 
field strength and the gadolinium concentrations.
We used Gd-DTPA and Gd-EOB-DTPA, which are currently 
two of the most widely available gadolinium chelates. Gd-
DTPA is an extracellular paramagnetic contrast agent and it 
is predominantly excreted through the kidneys (12). Due to 
the rapid renal elimination and the lack of biliary excretion, 
a contrast effect in the bile ducts cannot be achieved with 
this substance. Gd-EOB-DTPA is a hepatobiliary MRI contrast 
agent with high T1 relaxivity in the liver. It is cleared from 
the body by two elimination routes: receptor-specific uptake 
by the hepatocytes with subsequent biliary excretion and 
glomerular filtration in the kidneys with subsequent urinary 
excretion (13). Hepatobiliary elimination accounts for 
approximately 50% of the total elimination. The peak liver 
signal intensity is observed 20 minutes after injection and 
this is followed by plateau-like enhancement over the next 
two hours. In two studies, visualization of the common bile 
duct occurred within 10 minutes after injection and this 
persisted for more than 120 minutes in healthy volunteers. 
As such, this biliary excretion makes it possible to use 
this contrast agent for T1-weighted MR cholangiography 
(10, 14). Bile duct patency can be directly visualized with 
this technique. However, Gd-EOB-DTPA is not approved for 
patients less than 18 years old because of its unknown 
safety and efficacy (13). We think that diverse pediatric 
biliary diseases, including biliary atresia and choledochal 
cysts, can be good candidates for the use of Gd-EOB-DTPA, 
although a proper delay time is still a problem in patients 
with delayed biliary excretion. Further evaluation of this is 
needed.
Rohrer et al. (4) reported on the T2 relaxivities of each 
gadolinium chelate for 1.5T and 3T and they found a 
difference between the contrast agents. Our study also 
showed different T2 relaxation times for each gadolinium 
chelate (p < 0.001). However, these were not significantly 
influenced by the signal intensities and the CNRs, which 
could be more important when clinically interpreting the 
imaging.
The effects of different magnetic field strengths were also 
evaluated in this study and they were found to influence 
the signal intensities, the CNRs and the T2 relaxation times. 
As expected, the signal intensities were higher on 3T. 
However, the CNRs were lower on 3T despite an increase in 
the signal-to-noise ratio with high magnetic field strength. 
This may be due to the susceptibility effect of gadolinium. 
The T2 relaxation time also decreased on 3T, and this can 
be explained by the T2-shortening effect of high magnetic 
field strength.
With regard to the effect of the gadolinium concentration, 
both the signal intensities and the T2 relaxation times 
showed a negative correlation with the gadolinium 
concentration in our phantom study, suggesting the T2-
shortening effect of gadolinium. Gadolinium chelate is 
expected to reach an equilibrium state in no more than 
3-5 minutes after IV administration and it is thought to 
be distributed in the vascular and extracellular spaces at 
an approximate concentration of 0.1-0.5 mmol/kg (11). 
Our phantom study revealed a T2-shortening effect of 
gadolinium chelate at these concentrations. Therefore, the 
CNR of the saline syringe tube should increase after contrast 
injection in the sponge phantom with Gd-DTPA. However, 
the CNRs did not change (Fig. 3). Furthermore, the CNR 
was also equivocal in the cases with Gd-EOB-DTPA (Fig. 4). 
Neither the maximum CNR nor the optimal delayed imaging 
time with a given gadolinium concentration were achieved 
in this study. This may have been due to the small diameter 
of the syringe used to simulate a bile duct and a partial 
volume effect. An in vivo study may be warranted to further 
explore these questions. The CNRs did not change according 
to the different gadolinium concentrations.  However, they 
were higher on 1.5T with both Gd-DTPA and Gd-EOB-DTPA. 
Additionally, Gd-EOB-DTPA is not recommended for the T2-
weighted MRCP sequence because of its properties of biliary 
excretion (1, 15). Our study also revealed a decreased 
CNR of the syringe tube (simulating a bile duct) with a 
higher gadolinium concentration. As such, we suggest that 
gadolinium-enhanced T2-weighted MRCP with Gd-DTPA on 
1.5T could increase the CNR without a temporal delay.
In conclusion, there is a T2-shortening effect of 
gadolinium and this shows a negative correlation with the 
gadolinium concentration for both the signal intensity and 
the T2 relaxation time. Additionally, a higher CNR can be 
obtained with Gd-DTPA at 1.5T. 
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